Published in Protein Sci on December 01, 2013
Nrf2-a therapeutic target for the treatment of neurodegenerative diseases. Free Radic Biol Med (2015) 0.95
Monitoring Keap1-Nrf2 interactions in single live cells. Biotechnol Adv (2014) 0.91
Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway. Bioorg Med Chem Lett (2015) 0.78
Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein. J Virol (2015) 0.76
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
The green fluorescent protein. Annu Rev Biochem (1998) 34.17
Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev (1999) 13.43
Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A (2002) 8.01
Understanding, improving and using green fluorescent proteins. Trends Biochem Sci (1995) 7.51
Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol (2003) 6.91
Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A (2008) 5.18
Fluorescent protein FRET: the good, the bad and the ugly. Trends Biochem Sci (2007) 3.99
Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol (2006) 3.27
Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem (1988) 3.12
Chemoprevention of cancer. Cancer Res (1985) 2.78
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling. EMBO J (2006) 2.67
Using GFP in FRET-based applications. Trends Cell Biol (1999) 2.55
Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal (2010) 2.45
Adding calorimetric data to decision making in lead discovery: a hot tip. Nat Rev Drug Discov (2009) 1.74
Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev (2012) 1.72
Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents. Cancer Res (2006) 1.51
Electrophilic tuning of the chemoprotective natural product sulforaphane. Proc Natl Acad Sci U S A (2010) 1.37
Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci U S A (2013) 1.25
SPR-based fragment screening: advantages and applications. Curr Top Med Chem (2007) 1.13
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorg Med Chem (2013) 1.07
The Keap1-Nrf2 system as an in vivo sensor for electrophiles. Nitric Oxide (2011) 1.06
Development of FRET assay into quantitative and high-throughput screening technology platforms for protein-protein interactions. Ann Biomed Eng (2010) 1.03
Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction. Bioorg Med Chem Lett (2013) 1.03
Quantitative analysis of multi-protein interactions using FRET: application to the SUMO pathway. Protein Sci (2008) 1.00
Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography. FEBS Lett (2013) 0.98
Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction. Free Radic Biol Med (2011) 0.94
Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity. Org Biomol Chem (2013) 0.91
Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction. J Biomol Screen (2011) 0.91
Kinetic analyses of Keap1-Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance. Chem Biol Drug Des (2011) 0.91
Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol Lett (2000) 0.83
Applications of isothermal titration calorimetry in protein science. Acta Biochim Biophys Sin (Shanghai) (2008) 0.83
A universal method for fishing target proteins from mixtures of biomolecules using isothermal titration calorimetry. Protein Sci (2008) 0.81
Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction. Free Radic Biol Med (2011) 0.94
Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity. Org Biomol Chem (2013) 0.91
Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78. Mol Cancer Ther (2008) 0.87
Supramolecular domains in mixed peptide self-assembled monolayers on gold nanoparticles. Chembiochem (2008) 0.85
PMI: a ΔΨm independent pharmacological regulator of mitophagy. Chem Biol (2014) 0.82
An extended pyrrolobenzodiazepine-polyamide conjugate with selectivity for a DNA sequence containing the ICB2 transcription factor binding site. J Med Chem (2013) 0.81
Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box. Bioorg Med Chem Lett (2011) 0.80